Bile Acid Transporters Are Expressed and Heterogeneously Distributed in Rat Bile Ducts
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Cholangiocytes are capable of reabsorbing bile salts from bile, but the pathophysiological significance of this process is unclear. To this end, we detected the expression and distribution of bile acid transport proteins in cholangiocytes from normal rat liver and analyzed the possible pathophysiological significance. Methods: Bile duct tissues of Sprague-Dawley rats were isolated by enzymatic digestion and mechanical isolation, and then divided into large and small bile duct tissues. Immunohistochemistry, real-time polymerase chain reaction and Western blotting were used to determine the expression of the apical sodium-dependent bile acid transporter (ASBT), ileal bile acid binding protein (IBABP), and basolateral organic solute transporter α (Ostα) in the biliary tract system of rats. Differences in the expression and distribution of these proteins were analyzed. Results: In cholangiocytes, ASBT and IBABP were mainly expressed in cholangiocytes of the large bile ducts, in which the expression of both was significantly higher than that in the small ducts (p<0.05). Ostα was simultaneously expressed in cholangiocytes of both the large and small bile ducts, showing no significant difference in expression between the two groups of bile ducts (p>0.05). Conclusions: Bile acid transporters are expressed and heterogeneously distributed in rat bile ducts, indicating that bile acid reabsorption by cholangiocytes might mainly occur in the large bile ducts. These findings may help explore the physiology of bile ducts and the pathogenesis of various cholangiopathies.
Abstract
Background/Aims: Cholangiocytes are capable of reabsorbing bile salts from bile, but the pathophysiological significance of this process is unclear. To this end, we detected the expression and distribution of bile acid transport proteins in cholangiocytes from normal rat liver and analyzed the possible pathophysiological significance. Methods: Bile duct tissues of Sprague-Dawley rats were isolated by enzymatic digestion and mechanical isolation, and then divided into large and small bile duct tissues. Immunohistochemistry, real-time polymerase chain reaction and Western blotting were used to determine the expression of the apical sodium-dependent bile acid transporter (ASBT), ileal bile acid binding protein (IBABP), and basolateral organic solute transporter α (Ostα) in the biliary tract system of rats. Differences in the expression and distribution of these proteins were analyzed. Results: In cholangiocytes, ASBT and IBABP were mainly expressed in cholangiocytes of the large bile ducts, in which the expression of both was significantly higher than that in the small ducts (p<0.05). Ostα was simultaneously expressed in cholangiocytes of both the large and small bile ducts, showing no significant difference in expression between the two groups of bile ducts (p>0.05). Conclusions: Bile acid transporters are expressed and heterogeneously distributed in rat bile ducts, indicating that bile acid reabsorption by cholangiocytes might mainly occur in the large bile ducts. These findings may help explore the physiology of bile ducts and the pathogenesis of various cholangiopathies.
참고문헌 (24)
- Alvaro D, "Regulation and deregulation of cholangiocyte proliferation", J Hepatol, 33, pp.333~340 (2000)
- Maroni L, "Functional and structural features of cholangiocytes in health and disease", Cell Mol Gastroenterol Hepatol, 1, pp.368~380 (2015)
- Han Y, "Recent advances in the morphological and functional heterogeneity of the biliary epithelium", Exp Biol Med, 238, pp.549~565 (2013)
- Priester S, "Involvement of cholangiocyte proliferation in biliary fibrosis", World J Gastrointest Pathophysiol, 1, pp.30~37 (2010)
- Benedetti A, "A morphometric study of the epithelium lining the rat intrahepatic biliary tree", J Hepatol, 24, pp.335~342 (1996)
- Masyuk AI, "Cholangiocyte primary cilia in liver health and disease", Dev Dyn, 237, pp.2007~2012 (2008)
- Jung D, "FXR-induced secretion of FGF15", 19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway, 2014, pp.466, 1011~1019
- Marin JJ, "Bile acids in physiology, pathology and pharmacology", Curr Drug Metab, 17, pp.4~29 (2015)
- Xia X, "Bile acid interactions with cholangiocytes", World J Gastroenterol, 12, pp.3553~3563 (2006)
- Ferrebee CB, "Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids", Acta Pharm Sin B, 5, pp.129~134 (2015)
- Cheng L, "Role of cholangiocyte bile Acid transporters in large bile duct injury after rat liver transplantation", Transplantation, 90, pp.127~134 (2010)
- Glaser SS, "Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium", Lab Invest, 89, pp.456~469 (2009)
- Hall C, "Regulators of cholangiocyte proliferation", Gene Expr, 17, pp.155~171 (2017)
- Sawada R, "Interleukin-33 overexpression reflects less aggressive tumour features in large-duct type cholangiocarcinomas", Histopathology, 73, pp.259~272 (2018)
- Alpini G, "Activation of alpha(1)-adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1", Hepatology, 53, pp.628~639 (2011)
- Munoz-Garrido P, "Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease", J Hepatol, 63, pp.952~961 (2015)
- Lozano E, "Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development", Mol Cancer Res, 12, pp.91~100 (2014)
- Alrefai WA, "Bile acid transporters : structure, function, regulation and pathophysiological implications", Pharm Res, 24, pp.1803~1823 (2007)
- Camilleri M, "Therapeutic targeting of bile acids", Am J Physiol Gastrointest Liver Physiol, 309, pp.G209~G215 (2015)
- Hofmann AF, "Key discoveries in bile acid chemistry and biology and their clinical applications : history of the last eight decades", J Lipid Res, 55, pp.1553~1595 (2014)
- Dawson PA, "Role of the intestinal bile acid transporters in bile acid and drug disposition", Handb Exp Pharmacol, 201, pp.169~203 (2011)
- Song P, "Individual bile acids have differential effects on bile acid signaling in mice", Toxicol Appl Pharmacol, 283, pp.57~64 (2015)
- Chothe PP, "Resveratrol promotes degradation of the human bile acid transporter ASBT(SLC10A2)", Biochem J, 459, pp.301~312 (2014)
- Schaffner CA, "The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes", Liver Int, 35, pp.1152~1161 (2015)